Biopharmaceutical Manufacturing, Upstream, Downstream …
Will the Biosecure Act impact the pharma industry?
Automation in cell therapy manufacturing and CAR-T therapy: Cytiva
2024 Nobel prize in medicine for microRNA discovery
‘Biotech remains the biopharma industry’s engine of …
WEBJun 28, 2022 · Biotech performed ‘exceptionally well’ in 2021, driven by the COVID-19 crisis. That’s against a backdrop where the pandemic is projected to result in a cumulative reduction in global medicine spending …
Speed, flexibility and innovation: Rethinking the way …
WEBNov 29, 2021 · News and analysis on the clinical development and manufacture of large molecule drugs. A new report reveals that “speed-to-market” has jumped up from a lower-ranking business driver before the …
Novartis investing US$300m in next generation biotherapeutics …
How do you expand cell therapy manufacturing to …
WEBMay 23, 2022 · The closed system reduces the footprint that is required in cleanrooms, lowering the per patient manufacturing cost by up to 70% for most cell therapy workflows, he said. It also accelerates and de-risks …
Opportunities for US manufacturing in biologics
WEBAug 3, 2021 · There’s an opportunity for the US to lead in advanced biologicals; as well as manufacturing in viral vectors and cell and gene therapies, according to CPhI’s insight’s report ‘US Pharma Market 2022 …
Downstream biomanufacturing set for high growth over the next …